Uncovering the Complete Picture: Transforming Rare Disease Care for Every Patient

Diagnostic odysseys in rare disease often leave critical gaps in care. When standard approaches fall short, comprehensive genomic insight is essential to illuminating those blind spots. Join Kelly Hagman, MS, CGC, to explore how Ambry is setting a new bar for clinical whole genome sequencing, delivering unprecedented clarity, maximizing diagnostic yield, and driving equitable care across diverse patient populations.

In this session, you’ll discover how Ambry helps clinicians get the most out of every genome through:

-Broader Variant Calling: Capturing complex structural variants, intronic changes, and non-coding regions.
-Pangenome Graphical Mapping: Leveraging global genomic diversity to reduce reference bias and improve diagnostic accuracy for underrepresented populations.
-Functional Precision with RNA: Utilizing GenomeReveal™️ to clarify splicing impacts and convert VUSs into definitive answers.
-Continuous Care with Patient for Life™️: A first-of-its-kind, lab-driven reanalysis program that automatically updates patient reports as new gene-disease associations are discovered, ensuring genomic data continues to deliver lifelong clinical value so no rare disease patient is left behind.

*CEU credit is not available for this webinar.*

Kelly Hagman
Kelly Hagman, MS, CGC
Speaker
Kelly Hagman, MS, CGC, has been part of Ambry Genetics since 2009 and today serves as Vice President of Medical Affairs and Strategic Integration at Tempus Diagnostics. She brings deep expertise in genomic technology together with her background as a genetic counselor. Since Tempus acquired Ambry, she has led the medical integration of the two companies, and her teams built a new Medical Market Access function that helps patients get coverage for testing. She has authored more than 55 peer-reviewed publications. Along the way, she launched the industry’s first clinical exome, founded Ambry’s Medical Affairs department, and created flagship programs including EducateNext, and Ambry Knows Genes, and Patient for Life.